We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$774M
AUM Growth
-$81.1M
Cap. Flow
-$98.8M
Cap. Flow %
-12.78%
Top 10 Hldgs %
52.83%
Holding
53
New
7
Increased
4
Reduced
13
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 34.6%
2 Technology 26.05%
3 Consumer Discretionary 18.05%
4 Consumer Staples 6.7%
5 Financials 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRWD icon
26
Ironwood Pharmaceuticals
IRWD
$686M
$10.8M 1.4%
929,714
-40,800
-4% -$501K
AVAN.U
27
DELISTED
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
$10.1M 1.31%
1,000,000
ATRA icon
28
Atara Biotherapeutics
ATRA
$74.4M
$9.72M 1.26%
24,660
-12,404
-33% -$5.22M
WRAC
29
DELISTED
Williams Rowland Acquisition Corp.
WRAC
$9.38M 1.21%
950,000
QTRX icon
30
Quanterix
QTRX
$164M
$7.47M 0.97%
176,259
+31,900
+22% +$1.49M
CUTR
31
DELISTED
Cutera, Inc.
CUTR
$7.32M 0.95%
177,022
+19,500
+12% +$800K
MSOS icon
32
AdvisorShares Pure US Cannabis ETF
MSOS
$856M
$4.52M 0.58%
+176,500
New +$4.87M
SRZN icon
33
Surrozen
SRZN
$254M
$4.51M 0.58%
46,667
LIVN icon
34
LivaNova
LIVN
$4.42B
$4.01M 0.52%
45,900
-80,700
-64% -$6.73M
TECH icon
35
Bio-Techne
TECH
$11.2B
$3.72M 0.48%
28,760
DMTK
36
DELISTED
DermTech, Inc. Common Stock
DMTK
$3.57M 0.46%
+226,100
New +$5.43M
ABCM
37
DELISTED
Abcam PLC
ABCM
$2.45M 0.32%
103,850
NEXI
38
DELISTED
NexImmune, Inc. Common Stock
NEXI
$1.84M 0.24%
16,000
NAUT icon
39
Nautilus Biotechnolgy
NAUT
$126M
$1.5M 0.19%
289,000
+163,000
+129% +$872K
DXCM icon
40
DexCom
DXCM
$32.1B
$1.44M 0.19%
10,708
-20,704
-66% -$2.98M
OLK
41
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$836K 0.11%
45,925
SRZNW icon
42
Surrozen Inc Warrant
SRZNW
$69.7K
$537K 0.07%
466,666
TOST icon
43
Toast
TOST
$18.8B
$273K 0.04%
+7,861
New +$364K
WRAC.WS
44
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$247K 0.03%
475,000
MYPSW
45
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
$84K 0.01%
141,105
ALNY icon
46
Alnylam Pharmaceuticals
ALNY
$27.1B
-59,804
Closed -$11.3M
AMWL icon
47
American Well
AMWL
$181M
-52,306
Closed -$9.53M
FTDR icon
48
Frontdoor
FTDR
$5.1B
-596,758
Closed -$25M
MSGS icon
49
Madison Square Garden
MSGS
$9.57B
-95,700
Closed -$17.8M
SEER icon
50
Seer Inc
SEER
$122M
-108,719
Closed -$3.75M

Similar funds

Bridger Management's Q4 2021 Portfolio in Review

As of Q4 2021, Bridger Management held 53 positions worth $774M, down 9.5% from $855M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Bridger Management withdrew a net $98.8M in Q4 2021, closing 8 positions and reducing 13 holdings. Its most notable exit was Frontdoor, an estimated $25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bridger Management opened a new position in iRhythm Holdings worth $36.4M.

  • Bridger Management's largest Q4 2021 buy was iRhythm Holdings: 309,100 shares worth $36.4M.
  • Bridger Management added most to HCA Healthcare in Q4 2021, an estimated $3.87M increase.
  • Bridger Management's biggest Q4 2021 reduction was Centene, cutting an estimated $17M.
  • Bridger Management fully exited Frontdoor in Q4 2021, selling an estimated $25M.
  • Bridger Management's ten largest holdings make up 53% of its $774M portfolio in Q4 2021.
  • Bridger Management opened 7 new positions and closed 8 in Q4 2021.
  • Bridger Management's portfolio value fell 9.5% quarter-over-quarter to $774M.

Based on Bridger Management's 13F filing for Q4 2021, filed 14 Feb 2022.